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Abstract: The 43 kDa subunit of the chloroplast signal recognition particle, cpSRP43, is an 
ATP-independent chaperone essential for the biogenesis of the light harvesting chlorophyll-
binding proteins (LHCP), the most abundant membrane protein family on earth. cpSRP43 is 
activated by a stromal factor, cpSRP54, to more effectively capture and solubilize LHCPs. The 
molecular mechanism underlying this chaperone activation is unclear. Here, a combination of 
hydrogen-deuterium exchange, electron paramagnetic resonance, and NMR spectroscopy 
experiments reveal that a disorder-to-order transition of the ankyrin repeat motifs in the substrate 
binding domain of cpSRP43 drives its activation. An analogous coil-to-helix transition in the 
bridging helix, which connects the ankyrin repeat motifs to the cpSRP54 binding site in the 
second chromodomain, mediates long-range allosteric communication of cpSRP43 with its 
activating binding partner. Our results provide a molecular model to explain how the 
conformational dynamics of cpSRP43 enables regulation of its chaperone activity and suggest a 
general mechanism by which ATP-independent chaperones with cooperatively folding domains 
can be regulated.  
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Introduction 
 Cells employ a diverse network of chaperones to assist in a variety of processes needed to 
maintain protein homeostasis, including de novo protein folding, sequestration and remodeling of 
misfolded proteins, and localization to target cellular compartments. To precisely time the 
capture, folding, and release of their substrates, chaperones undergo controlled structural 
rearrangements to complete their functional cycle. Many chaperones, such as members of the 
ubiquitous Hsp70, Hsp90, and Hsp100 families, use regulated ATPase cycles to alternate 
between conformations that promote client capture or release and even to remodel client 
conformations during this cycle [1]–[3]. ATP-independent small heat shock proteins undergo 
changes in oligomeric state and/or unfolding transitions upon activation under stress conditions 
[4]–[7].  
A distinct group of chaperones are dedicated to the post-translational targeting of integral 
membrane proteins, and their chaperone cycle needs to be spatially regulated. Membrane 
proteins contain hydrophobic transmembrane domains (TMDs) that are highly prone to 
misfolding and aggregation in the aqueous environments where they are initially synthesized. 
Therefore, nascent membrane proteins require effective molecular chaperones to protect them 
from aggregation, maintain them in an insertion-competent state, and guide them to the 
appropriate cellular membrane. Many examples illustrate the intimate link between chaperone 
function and membrane protein biogenesis: SecB, Skp and SurA protect bacterial outer 
membrane proteins [8]–[14], and components of the GET and SND pathways deliver membrane 
proteins harboring late TMDs [15], [16]. A conserved feature of membrane protein chaperones is 
that they need to turn ‘on’ in the aqueous phase to tightly capture and protect membrane protein 
clients, and to turn ‘off’ at the target membrane to facilely release clients for membrane 
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insertion. Failure to properly protect membrane proteins leads to the formation of toxic 
aggregates and is implicated in a variety of neurodegenerative disease pathologies [17]. Despite 
their importance, only a few membrane protein chaperone systems have been studied in detail, 
and the regulatory mechanism of most membrane protein chaperones remain not well 
understood. 
The light harvesting chlorophyll-binding proteins (LHCPs) in green plants comprise 
~50% of the proteins in the thylakoid membrane and are the most abundant family of membrane 
proteins on earth [18]. Like the vast majority (>95%) of organellar proteins, LHCPs are 
translated in the cytosol and imported into the chloroplast stroma, where they form a soluble 
“transit complex” with the chloroplast signal recognition particle (cpSRP) comprised of 
cpSRP43 and cpSRP54 subunits [19]–[22]. Via the interaction of cpSRP54 with the membrane-
bound receptor, cpFtsY, the transit complex is recruited to the thylakoid membrane and hands off 
LHCP to the Alb3 translocase [23]–[29]. Alb3 mediates the insertion of LHCPs into the 
membrane, where they assemble into the light harvesting complex that forms the antenna of the 
photosystem reaction center [18], [30]. The abundance of LHCPs and their crucial roles in 
energy generation of green plants necessitate highly effective chaperones to assist in their 
biogenesis, making it a robust system to understand the function and mechanism of membrane 
protein chaperones. 
The cpSRP43 subunit in cpSRP is responsible for chaperoning LHCPs during their 
targeted delivery to the thylakoid membrane [31], [32]. cpSRP43 contains a substrate binding 
domain (SBD) consisting of four ankyrin repeat motifs capped by an N-terminal chromodomain 
(CD1) and a C-terminal bridging helix (BH) [32]–[34]. The ankyrin repeat motifs in the SBD 
recognize a conserved L18 motif between TMD2 and TMD3 of LHCP [22], [33]–[36]. The SBD 
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also forms extensive contacts with all three TMDs in LHCP, potentially via hydrophobic 
surfaces on the ankyrin repeat motifs and the BH, to protect them from aggregation [37]. The 
chaperone activity of the cpSRP43 SBD is regulated by interaction partners that bind at two 
additional chromodomains C-terminal to the SBD. Wildtype cpSRP43 displays lower chaperone 
activity than the SBD, but is activated upon binding of a motif from the C-terminus of the 
cpSRP54 M-domain (54M) to CD2 [38]–[40]. In contrast, the stromal domain of the Alb3 
translocase binds to CD3 and triggers the selective release of the LHCP TMDs from cpSRP43 
[34]. These regulations in chaperone activity strongly correlated with changes in the HSQC 
spectra of cpSRP43. At least two component peaks were observed for multiple residues in CD1 
in apo cpSRP43. One of the component peaks became dominant under activating conditions, 
such as in the isolated SBD or upon addition of the 54M or L18 peptide, whereas the opposite 
component peak became dominant in the presence of the Alb3 stromal domain [34]. These 
observations led to a model in which free cpSRP43 samples both a chaperone-inactive, open 
state and a chaperone-active, closed state. cpSRP54 drives cpSRP43 to the closed state to enable 
effective capture of LHCPs in the stroma, whereas the Alb3 translocase drives its transition to 
the open state to effect the facile release of LHCPs at the site of membrane insertion. 
Despite this conceptual framework, the nature of the conformational changes underlying 
cpSRP43 activation remains poorly understood. Due to crowding of the HSQC spectra, 
component cross peaks for both the open and closed states of cpSRP43 could be assigned for 
only 12 residues in CD1, whereas only the peaks for the closed state were assigned for the 
majority of residues in the SBD [34]. Crystal structures are available for the SBD and SBD-CD2 
fragments bound to the 54M peptide, which primarily capture the closed conformation [38], [41]. 
A complete picture of cpSRP43’s conformational landscape throughout its chaperone cycle is 
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therefore lacking. To address this gap in knowledge, we used a combination of biophysical 
approaches, including hydrogen-deuterium exchange (HDX), electron paramagnetic resonance 
(EPR) and NMR spectroscopy, to probe the structural changes of cpSRP43 during its activation. 
Our results show that the ankyrin repeat motifs and the BH of cpSRP43 undergo a disorder-to-
order transition, whereas CD1 shifts between two folded structures during the open-to-closed 
rearrangement. We propose a model in which a coil-to-helix transition in the BH is propagated 
across the ankyrin repeat domain of cpSRP43 and allows long-range communication of the 
activating ligand to drive folding of the sites required for substrate binding. 
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Results 
The cpSRP43 SBD is better solvent-protected in the activated state 
To probe for potential structural changes in the cpSRP43-SBD during its activation, we 
compared the amide hydrogen/deuterium exchange (HDX) efficiencies between free cpSRP43 
and cpSRP43 bound to a peptide containing its recognition motif on LHCP (L18) or on the M-
domain of SRP54 (54M peptide; Figure 1). HDX coupled to mass spectrometry (MS) measures 
the local solvent accessibility of amide protons, which vary the most at sites of protein-protein 
interactions or sites undergoing largescale conformational changes [42]. Over 160 peptides were 
observed and analyzed from each MS spectrum of cpSRP43, covering >90% of its protein 
sequence across most domains (Fig. S1-S4). Many regions of cpSRP43 (CD1, ankyrin repeat 
motifs, BH, CD3, and the C-terminus of CD2) were identified by multiple peptides, providing 
redundant data that ensure reliable and accurate quantification. 
We found that both the L18 and 54M peptides induced slower H/D exchange of backbone 
amides in ankyrin repeat motifs 1-4 and the BH in the SBD of cpSRP43 (Figs. 1A, B and S1-S2). 
In general, the 54M peptide had a larger effect than L18 in reducing the rate of H/D exchange. 
Additional sites in CD2 also showed significantly lower HDX in the presence of 54M (Figs. 1B 
and S2), presumably due to shielding of the 54M binding site from solvent and possibly 54M-
induced local rearrangements in CD2. Although ligand-induced protection from H/D exchange 
could arise from either shielding of the ligand binding site or from induced conformational 
changes, the reduction in solvent accessibility was observed across almost all the helices in the 
SBD and includes regions that are remote from the immediate L18 or 54M binding sites. These 
results suggest that binding of the substrate (L18) and activator (54M) induce global changes in 
the structure or dynamics of cpSRP43-SBD that render this domain better solvent protected. 
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To directly test this model, we analyzed the H/D exchange profile of two previously 
identified superactive cpSRP43 mutants that are pre-organized into the active conformation: 
cpSRP43(intein), in which the short Gln-Val linker between the BH and CD2 was replaced by a 
longer and more flexible sequence; and cpSRP43-SBD, a construct containing only the SBD but 
lacking CD2 and CD3 [34]. Both mutants exhibit higher chaperone activity than wildtype 
cpSRP43, are predominantly in the active state based on HSQC NMR data, and largely bypass 
activation by cpSRP54 [34]. HDX analyses showed that, compared to wildtype cpSRP43, 
significant reductions in backbone solvent accessibility across the entire SBD, including the 
ankyrin repeat motifs and the BH (Figs. 1C, 1D and S3, S4), were observed with both mutants. 
In contrast, few changes in HDX efficiency were observed in CD1, CD2 and CD3 between these 
mutants and wildtype cpSRP43 (Fig. 1 and S1-4). The protection patterns in the SBD observed 
with the superactive chaperone mutants were similar to those induced by 54M and L18, although 
54M induced the strongest protections. Together, these results indicate that the SBD of cpSRP43, 
specifically the ankyrin repeats and BH, becomes better solvent protected in the activated state. 
 
Substrate and activator rigidify the cpSRP43 SBD 
To gain higher resolution information into the substrate and 54M-induced structural 
changes in cpSRP43-SBD, we used site-directed spin labeling and electron paramagnetic 
resonance (EPR) spectroscopy, which provides a sensitive probe for the local backbone mobility 
at sites of interest. The nitroxide probe (1-oxy-2,2,5,5-tetramethyl-3-pyrrolinyl-3-methyl) 
methanethiosulfonate (MTSSL) is small with a short spacer, which can be placed throughout a 
protein without significantly affecting structure [43]. The mobility of MTSSL is highly 
dependent on the local secondary or tertiary structure [44], which can be used to distinguish 
loops from helices and sites on the surface from those buried in the protein interior [45], [46]. 
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Using a previously characterized cysteineless cpSRP43 mutant that retains chaperone activity 
within 2-3 fold of wildtype cpSRP43 and is strongly activated by 54M ([37], Fig. S5), we 
introduced single cysteine mutations at selected residues in the SBD where the mutation affected 
chaperone activity less than three-fold (Fig. 2A & B and [37]). The native cysteine (C175) and 
the engineered single cysteines allowed site-specific labeling with MTSSL. We verified that the 
MTSSL-labeled cpSRP43 could still bind the 54M peptide with affinities that are within 3-fold 
of WT cpSRP43 (Figure S5A and [38]) and that 54M binding restored full chaperone activity of 
MTSSL-labeled cpSRP43 variants towards LHCP (Figure S5B & C). We measured the effects of 
54M and the substrate protein, LHCP, on the EPR spectra of spin-labeled cpSRP43. The changes 
in the EPR spectra were characterized by the linewidth of the central resonance (Fig. 2C and 2D, 
H0) and the overall breadth of the EPR spectra, especially the intensity of hyperfine splitting 
that arises from highly immobile populations of spin probes relative to the mobile population 
(Fig. 2C) [47]–[49]. 
All five spin labels in the ankyrin repeat motifs and the BH (C175, R192C, V205C, 
I253C, G264C) underwent significant EPR spectral changes upon binding the 54M peptide 
and/or LHCP (Figs. 2C and 2D, black vs. red and green). Four of the spin probes at these 
positions become less mobile, as reflected by an increase in the central linewidth and the 
reductions in the mobile fraction in the EPR spectra (Fig. 2C & D). For the remaining residue, 
R192C, changes in probe mobility were not obvious from the central linewidth but were readily 
detectable from changes in EPR spectral shape upon the addition of both 54M and LHCP, which 
showed a higher relative population of immobile species (Figs. 2C). As 54M binds outside the 
SBD (Fig. 1), the observed immobilization of multiple spin probes indicates long-range allosteric 
communications throughout the ankyrin repeat domain. On the other hand, none of the four spin 
probes in CD1 underwent significant spectral changes upon binding of 54M or LHCP (Figs. 2C 
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& D). Collectively, the EPR data show that the 54M- and substrate-induced conformational 
changes in the cpSRP43-SBD lead to increased backbone rigidity of the ankyrin repeat domain 
and the BH, but these changes did not propagate to CD1. 
 
NMR spectroscopy reveals disorder-to-order transitions in the SBD 
 To obtain dynamic information on the changes in the cpSRP43-SBD during its activation, 
we employed site specific fluorine-labeling and NMR spectroscopy. We attached the 3-bromo-
1,1,1-trifluoropropan-2-one (BTFA) probe to single cysteines engineered at surface-exposed 
residues throughout cysteineless cpSRP43 and collected 1D 19F-NMR spectra (Fig. 3A). To test 
whether cysteine mutation and BTFA-labeling disrupted the activity or activation of cpSRP43, 
we measured the ability of each BTFA-labeled cpSRP43 variant to prevent LHCP aggregation 
with and without 54M present using light scattering assays (Fig. S6). Only the variants that 
retained chaperone activity and could be activated by 54M were subjected to further NMR 
analysis. 
Most cpSRP43 variants labeled with a single BTFA probe produced spectra with two or 
more peaks. The spectra were deconvoluted into individual component peaks, which allowed us 
to extract three fitting parameters for each peak: the chemical shift, peak width, and peak area 
(Figs. 3B & Fig. S7). With the exception of residue L363C (in CD3), addition of the activating 
peptides, 54M or L18, changed the relative abundance of the component peaks at most BTFA 
labeled sites (Fig. 3C and D), whereas the chemical shifts of each component peak remained 
largely unchanged (Fig. S7). This supports the model that interaction partners stabilize specific 
conformational states that are already sampled by apo cpSRP43 [34]. We assigned the 
component peaks that increased in relative abundance in response to L18 or 54M to the 
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chaperone-active closed conformation, and those that reduced in abundance upon L18 and 54M 
binding to the chaperone-inactive open conformation (Fig 4A). In contrast to most probes in the 
SBD, we detected only one peak for the BTFA probe in CD3 (L363C) that was unchanged upon 
ligand binding; this is consistent with previous observations from amide HSQC data that CD3 
does not sense or respond to 54M or L18 binding [34]. Finally, 19F Diffusion Ordered 
Spectroscopy (DOSY) measurements on apo cpSRP43 D150C-BTFA showed nearly identical 
diffusion coefficients for the two component peaks (7×10-7 cm2 s-1; Figure S8), excluding the 
possibility that one of the peaks arises from oligomerization [50]. The ability to observe both 
conformations of cpSRP43 in 19F-NMR allowed us to directly extract information about the 
structural changes during its activation. 
We first compared the chemical shifts of 19F-BTFA labeled cpSRP43 between the closed 
and open conformations, which provide information on the local environment of the BTFA 
probes. The 19F peaks for probes in Ank1, Ank3 and Ank4 (D150C, E211C, E221C, and E236C) 
shifted significantly upfield in the open conformation compared to the closed conformation (Fig. 
S7 and S9), suggesting that these sites are more solvent exposed in the open conformation [51], 
[52]. The 19F peaks for the probe in the BH (I253C) showed the opposite change; however, the 
complexity of the 19F spectra for I253C-BTFA suggests the presence of additional interactions or 
conformational states that complicate interpretation of its chemical shift values. Importantly, the 
component peaks for the closed conformation are well dispersed across all the BTFA probes in 
the ankyrin repeat motifs and the BH (Fig. S7 and Fig. 3D, blue circles). In contrast, the open 
conformation peaks for probes in the first three ankyrin repeats are narrowly dispersed around -
84.4 ppm (Fig. S7 and Fig. 3D, red circles). This strongly suggests that, in contrast to the well-
folded, closed conformation of cpSRP43 in which each BTFA probe is in a unique chemical 
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environment, many sites in the ankyrin repeat motifs and the BH are partially disordered in the 
open conformation.  
To identify changes in protein dynamics upon ligand-induced activation of cpSRP43, we 
compared the peak widths of the BTFA probes between the open and closed conformations. In 
the closed state, the 19F linewidths are relatively uniform for the apo cpSRP43 and its complexes 
with 54M and L18 (Fig. S7, 4B and 4C). For all BTFA probes in the ankyrin repeat motifs and 
the BH, the 19F peaks corresponding to the open conformation are significantly broader than 
those for the closed conformation (Fig. 3D and 3E). This suggests conformational fluctuations to 
the open state are occurring on the μs – ms time scale [53] and is consistent with the evidence 
from HDX and EPR that the SBD in apo cpSRP43 is flexible and becomes more rigid upon 
binding of L18 or 54M. The greatest broadening was observed for BTFA probes in Ank3, Ank4, 
and the BH (E221C, E236C, and I253C; Fig 4C), suggesting that the C-terminal half of the SBD 
is particularly flexible in the open conformation. These observations of structural disorder are 
analogous to the findings with IKBa [54], [55], Notch [56], [57], and p19(INK4d) [58], and 
appear to be a conserved feature among ankyrin repeat domain proteins [59]. In contrast, the 
component peaks for both the open and closed conformations have similarly narrow peak widths 
for BTFA probes in CD1 (Y119C) (Fig. 3D and E), suggesting that CD1 shifts between two 
well-folded structures during the open-to-closed transition.  
To obtain additional evidence for a disorder-to-order transition during the open-to-closed 
rearrangement in cpSRP43, we tested the effect of urea on the 1H, 15N-HSQC TROSY spectra of 
apo cpSRP43. If the open state is partially disordered and the closed state is fully folded, 
denaturant should shift the equilibrium towards the open state. Previous HSQC NMR studies of 
cpSRP43 identified 12 residues in CD1 that show two component cross peaks; the change in 
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their relative abundance upon addition of L18 and 54M peptide further allowed the assignment 
of the peaks to the open or closed conformation [34]. Intriguingly, titration of low doses of urea 
(up to 0.4 M) significantly reduced the component cross peaks for the closed conformation, with 
a corresponding increase in the intensity of the component cross peak for the open conformation 
(example for S92 shown in Fig. 4A and 4B). The same reduction was observed for all the 
residues in CD1 for which component cross peaks could be confidently assigned (Fig. 4C). 
These results show that denaturant such as urea promotes the open conformation in cpSRP43 and 
moreover, that the closed conformation of cpSRP43 is only marginally more stable than the open 
conformation and can therefore be substantially destabilized by low doses of denaturant. 
To further probe the conformational changes in the ankyrin repeat motifs, whose open 
conformation cross peaks could not be assigned in the 1H, 15N-HSQC TROSY spectra, we 
collected 19F NMR spectra on site-specifically BTFA-labeled apo cpSRP43 at increasing urea 
concentrations. Addition of 0.5 – 1 M urea reduced the component peak for the closed 
conformation, with a corresponding increase in the open conformation peaks for the BTFA 
probes in CD1 (Y119C) and Ank2–4 (D150C, E221C, E236C) (Fig. 4D and 4E), consistent with 
the effect of urea on the HSQC spectra (Fig. 4A and 4B). As described earlier, the open state 
peaks for BTFA probes in Ank3 (E221C) and Ank4 (E236C) were broad (Fig 4C) and suggested 
the presence of multiple conformations in intermediate exchange. In support of this model, 
multiple component peaks with narrower widths were observed for the open state in the presence 
of 0.5 – 1 M urea (Fig. 4D and E; ‘o1’ and ‘o2’), suggesting that urea accelerated the exchange 
between multiple conformations with different degrees of solvent exposure in the open state. For 
BTFA probes in the ankyrin repeat motifs, the component peaks for the open state also shifted 
upfield at 0.5 – 1 M urea (Fig. 4D), in contrast to the solvent effect of urea that shifts the 19F 
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peaks downfield in general (see Fig S10 for the effect of urea on a BTFA-labeled peptide, and 
Figure 4D for the effect of urea on the closed state peaks), suggesting that urea enhanced the 
solvent exposure of the open conformations at these sites [60], [61]. Finally, while the BTFA 
probes in the Ankyrin repeat domain were completely unfolded in 6M urea, only 35% of the 
probe in CD1 (Y119C) was unfolded in 6M urea (Fig, 5D and 5E), indicating that CD1 is tightly 
folded. Together, these results provide additional evidence that the ankyrin repeat motifs 
exchange between multiple partially unfolded conformations in the open state. 
In summary, 19F NMR allowed us to directly observe both the open and closed 
conformations in cpSRP43 and detect widespread disorder and flexibility in the ankyrin repeat 
motifs and the BH in the open conformation compared to the well-structured closed state. These 
results support findings from the H/D exchange and EPR data and provide direct evidence that 
the open-to-closed rearrangement of cpSRP43 involves widespread changes across the SBD, 
with the ankyrin repeat motifs and BH undergoing a disorder-to-order transition and CD1 
rearranging from one well-folded structure to another.  
 
A folded bridging helix is essential for chaperone activity. 
 To test if rearrangement to a well-folded ankyrin repeat domain is required for chaperone 
activity, we re-examined the effects of several mutations in the BH, which serves as a C-terminal 
capping element for the ankyrin repeat domain of cpSRP43 and bridges the ankyrin repeat motifs 
to the cpSRP54 binding site in CD2 (Fig. 5A). The BH is essential for maintaining the closed 
state of cpSRP43, and its deletion abolishes the chaperone activity of cpSRP43-SBD towards 
LHCP [34], indicating its critical role in cpSRP43 function. Multiple mutations in the BH have 
been introduced that disrupt either intra- or inter-helical contacts. The side chains of R252 and 
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E256 form an (i, i+4) salt bridge that stabilizes helix formation in the BH. I259 and E262 engage 
in close contacts with residues from the neighboring helix in Ank4 that stabilize inter-helical 
packing (Fig. 5A). Mutation of any of these residues severely disrupted cpSRP43’s chaperone 
activity (Fig. 5 B-D, Supplementary Table 1; see also [37]). In contrast, mutations of I253 and 
G264, which extend out towards the solvent in the closed conformation structure, did not 
substantially affect chaperone activity (Fig. S6 and [37]). The R252C, E256C, I259C and E262C 
mutations caused large deleterious effects on chaperone activity even with cpSRP43-SBD, in 
which CD2 and CD3 have been deleted (Fig. 5F), excluding models in which the mutational 
defects are caused by disruption of interactions between the BH and the nearby chromodomains. 
Thus, a properly folded BH is essential to arrange the cpSRP43-SBD into an active 
conformation, and any disruption of intra- or inter-helical interactions in the BH have strong 
deleterious effects on its chaperone activity. 
To provide additional evidence for this model, we tested the effect of 54M on these 
chaperone-deficient BH mutants. In the absence of 54M, none of them effectively suppressed the 
aggregation of LHCP, whereas LHCP was close to completely solubilized by these chaperone 
mutants in the presence of 54M (Figs. 5B and C, summarized in 5D and 5E). Deletion of the 
conserved C-terminal basic residues in 54M, which disrupts the binding of 54M with cpSRP43 
[62], abolished the rescue of chaperone activity (Fig. 5B, blue line), supporting the specificity of 
this effect. Further, 54M peptide was sufficient to produce the same rescue as the intact 54M 
domain (Fig. 5B, red vs. orange lines), excluding the possibility that the 54M domain contributed 
additional interaction sites for binding and solubilization of LHCP as previously proposed [19]. 
Thus, 54M was able to completely rescue deleterious mutations that severely disrupt helix 
formation in the BH and the chaperone activity of cpSRP43. The more extensive rescue of the 
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loss-of-function BH mutants compared to wildtype cpSRP43 are consistent with a model in 
which helix-destabilizing mutations shifted the conformational equilibrium of cpSRP43 further 
towards the open conformation, and are therefore more dependent on cpSRP54 for attaining the 
chaperone-active, closed conformation.  
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Discussion 
cpSRP43 is a small, ATP-independent chaperone that captures LHCPs imported into the 
chloroplast, protects them during their transit through the stroma, and delivers them to the 
translocation machinery for insertion into the thylakoid membrane [20]. Its small size, robust 
activity, well-characterized cellular role, and amenability to structural methods make it an 
excellent system to study the structure-dynamics-function relationship of a membrane protein 
chaperone. Previous work demonstrated that the chaperone activity of the cpSRP43 SBD is 
extensively regulated by binding of cpSRP54 in the stroma and the Alb3 translocase at the 
thylakoid membrane to effect spatial regulation of its coupled chaperone and protein targeting 
cycle [34]. In this work, we employed EPR, HDX, and NMR spectroscopy to define the 
structural changes in cpSRP43 upon its activation. Our results reveal extensive dynamics in the 
open conformation of cpSRP43 and strongly suggest that a disorder-to-order transition of the 
ankyrin repeat domain is responsible for its activation. Such a transition provides an attractive 
mechanism for long-range molecular communication of the SBD of cpSRP43 with binding 
partners that bind in its CD2 and CD3 domains.  
The results of multiple biophysical methods support a disorder-to-order transition during 
the activation of cpSRP43. Under conditions where cpSRP43 is chaperone-active, either in gain-
of-function variants pre-organized into the closed state or when it is bound to the 54M or L18 
peptides, we observed substantially reduced solvent exchange across the entire ankyrin repeat 
domain that could not be explained by ligand-induced shielding, whereas no such changes were 
observed in the chromodomains. These data suggest a global restructuring of the ankyrin repeat 
domain during its activation that renders it better protected from solvent. A clue to the nature of 
this structural change was provided by EPR studies, which showed that paramagnetic probes 
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across the ankyrin repeat motifs and BH displayed reduced local backbone mobility upon 
substrate or activator binding, whereas those in CD1 did not change. These results suggest that 
the ankyrin repeat domain is structurally more flexible in the open conformation sampled by apo 
cpSRP43.  
NMR experiments provided direct evidence for this model. With BTFA probes placed at 
sites throughout the SBD, we observed 19F peaks for both the open and closed conformations of 
cpSRP43, showing that these conformers interconvert slowly on the NMR time scale. For 19F-
BTFA probes in the ankyrin repeat domain, the peaks for the closed state have well dispersed 
chemical shift distributions and narrow peak widths, suggesting a defined three-dimensional fold 
consistent with the existing crystal structures of the cpSRP43 SBD. In contrast, the open state 
peaks are poorly dispersed and become increasingly broad towards the C-terminus of the ankyrin 
repeat domain, suggesting a high degree of disorder and dynamics that explain the HDX and 
EPR data. This model is further supported by the observation that low doses of urea shifts the 
conformational equilibrium towards the open conformation. In contrast to the ankyrin repeat 
motifs, both the open and closed state peaks for 19F-BTFA probes in CD1 are well dispersed and 
have narrow peak widths. We could further observe CD1 during the open-to-closed 
rearrangement using our assignments of both the open and closed state peaks for 12 residues in 
CD1 [34]. Despite the chemical shift differences in the amide HSQC cross peaks of these 
residues between the two states [34], the Cα and Cβ chemical shifts of both states are identical, 
suggesting little change in the secondary structure of CD1 during the open-to-closed 
rearrangement. As these residues cluster in a pair of β-strands that pack against Ank1 in the 
crystal structure of the closed state, their observed amide chemical shift differences between the 
two states likely reflect changes in the packing of Ank1 against CD1 in the open state [33]. 
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Together, these results indicate that CD1 remains well-folded in both the open and closed 
conformations, in agreement with the results from HDX and EPR analyses. The different effects 
of urea on CD1 and the ankyrin repeats in the open state further support a model where CD1 
adopts a stable fold in both the closed and open states, whereas the ankyrin repeat domain 
samples many partially unfolded conformations with relatively low stability but are driven to a 
single, well-folded closed conformation upon activation. Collectively, all three biophysical 
methods show that CD1 remains folded, while the ankyrin repeat domain undergoes a disorder-
to-order transition during the open-to-closed rearrangement that activates cpSRP43. 
A growing body of work points to the transition between folded and disordered structures 
in ATP-independent chaperones as a general mechanism to regulate chaperone activity [63]. 
Many of these chaperones are activated by order-to-disorder transitions. For example, small heat 
shock proteins de-oligomerize and become partially disordered upon heat stress to prevent 
misfolded proteins from aggregation [4], [7], [64]–[66]. Other stresses, such as acidic pH or 
oxidation, trigger unfolding transitions that activate chaperones such as HdeA, Hsp33, and 
Hsp26 [5], [6], [67], [68]. Our work shows that the opposite transition is used to activate 
cpSRP43, analogous to the Spy [13] and Skp [11] chaperones that protect nascent membrane 
proteins during their transit across the bacterial periplasm. The use of a disorder-to-order 
transition by cpSRP43 may arise in part from the folding property of the ankyrin repeat domain, 
in which the helices from individual repeats stack together to form a conserved, concave-shaped 
scaffold that presents binding surfaces for target proteins [69]. As interactions within each repeat 
are less stable than the interface between repeat motifs, ankyrin repeat domain proteins fold and 
unfold cooperatively despite the lack of long-range tertiary contacts [59]. Disorder-to-order 
transitions have been observed in IB, in which two of the ankyrin repeat motifs are disordered 
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in the apo protein but becomes structured upon binding to NFB [54], [55], with the notch 
intracellular domain upon binding the CSL transcription factor [56], [57], and with p19(INK4d) 
[58]. Importantly, a disorder-to-order transition of the ankyrin repeat domain provides an 
attractive molecular mechanism to explain the long-range molecular communication of cpSRP43 
with cpSRP54, whose binding in CD2 induces structural changes that propagate across the entire 
SBD. 
We propose a model in which a disorder-to-order transition in the ankyrin repeat domain 
of cpSRP43 reshapes the surface of the SBD to favor tight substrate binding (Fig. 6). Apo 
cpSRP43 extensively samples a chaperone-inactive, open conformation in which the ankyrin 
repeat domain is partially disordered and highly dynamic, especially towards the C-terminal 
repeat motifs and the BH. Binding of cpSRP54 in CD2, adjacent to the BH, induces a coil-to-
helix transition in the BH, enabling it to initiate inter-repeat interactions that propagate across the 
ankyrin repeat domain. This generates a well-folded, closed conformation in the SBD that 
presents both the L18 binding site and contiguous hydrophobic surfaces needed for efficient 
capture of the LHCP TMDs, whereas these contact surfaces would be disrupted in the partially 
unfolded open conformation. We speculate that other allosteric regulators, such as the Alb3 
translocase, could act by inducing additional conformational transitions in cpSRP43 when the 
targeting complex is delivered to the thylakoid membrane and thus favor selective release of 
LHCPs at the site of their membrane insertion.  
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Materials and Methods 
Protein Expression and Purification. Single cysteine mutants of Lhcb5 and cpSRP43 were 
constructed using the QuikChange Mutagenesis procedure (Stratagene) according to 
manufacturer’s instructions. WT and mutant cpSRP43, LHCP, and wildtype and mutant Lhcb5 
were overexpressed and purified as previously described [31]. 
Chaperone Activity of cpSRP43. The ability of cpSRP43 to prevent LHCP aggregation was 
measured as described previously [32], [36]. Aggregates were removed via ultracentrifugation in 
a TLA-100 rotor (Beckman Coulter) at 100,000 rpm for 30 min at 4 °C prior to the experiment. 
Light scattering experiments were performed by addition of 3 µL of 50 µM LHCP denatured 8M 
urea to 150 µL buffer D (50 mM KHEPES, pH 7.5 and 200 mM NaCl) or 2.5 µM cpSRP43 in 
buffer D. Light scattering was monitored at 360 nm on a UV-Vis spectrometer (Beckman 
Coulter) over time until equilibrium was reached. The percentage of soluble LHCP (% soluble) 
at equilibrium was plotted for each single-cysteine cpSRP43 mutant. 
Measurement of cpSRP54M binding. Experiments were carried out as previously described 
[34]. Binding of cpSRP43 to the cpSRP54M peptide (QKQKAPPGTARRKRKAC) was detected 
by changes in fluorescence anisotropy of Fluorescein labeled on the C-terminal cysteine. 
Anisotropy measurements were performed in 50 mM HEPES (pH 7.5), 200 mM NaCl at 25 °C 
on FluoroLog 3-22 (Yobin Yvon), using 10 nM fluorescein-labeled 54M peptide and indicated  
concentrations of MTSSL-labeled cpSRP43. The samples were excited at 500 nm, and the 
fluorescence anisotropy was recorded at 527 nm. To obtain the equilibrium dissociation constant 
between cpSRP43 and 54M, the data were fit to: 
  = +	∆ [ ] [ ] ([ ] [ ] ) ( ∙[ ][ ])∙[ ] , [1] 
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in which Aobs is the observed anisotropy value, A0 is the anisotropy value of 54M-fluorescein 
alone, ΔA is the change in anisotropy at saturating concentrations of cpSRP43, and Kd is the 
equilibrium dissociation constant for the interaction between MTSSL-labeled cpSRP43 and 
54M-fluorescein.  
Site-directed spin labeling and EPR measurements. Spin labeling reactions were performed in 
50 mM HEPES (pH 7.5), 200 mM NaCl. Reduced and degassed single cysteine mutants of 
cpSRP43 were labeled with a five- to tenfold molar excess of MTSSL (Toronto Research 
Chemicals) at room temperature in the dark for 2-3 h. Excess MTSSL was removed by gel 
filtration chromatography. The concentrations of spin-labeled samples were 30-100 µM 
cpSRP43, at least 10-fold higher than the apparent Kd of cysless cpSRP43 for 54M (0.39 µM 
[38]) and LHCP (2-3 µM [34]). After formation of the cpSRP43-LHCP complex, samples were 
ultracentrifuged at 100,000 rpm for 30 minutes to remove aggregated proteins. EPR spectra were 
acquired using a 9.4-GHz (X-band) EMX EPR spectrometer (Bruker) equipped with an ER 
4119HS cavity at 20-23 ºC. 5-30 scans were accumulated and averaged using microwave power 
of 5 mW with modulation amplitude set at 1 gauss and a magnetic field sweep width of 100 
gauss. The central linewidth of EPR spectra was the same at microwave powers of 0.2 – 5 mW. 
Less than 2% background labeling was observed; background subtraction was therefore not 
necessary. 
HDX detected by mass spectrometry. Solution-phase amide HDX experiments were carried 
out with a fully automated system (CTC HTS PAL, LEAP Technologies, Carrboro, NC; housed 
inside a 4 °C cabinet) as described previously with slight modifications [70]. HDX of full-length 
cpSRP43, cpSRP43(intein), and cpSRP43-SBD was performed at 4 °C in 50 mM KHEPES (pH 
8.0) and 200 mM NaCl using an automated system described previously [70]. All samples were 
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run at 10 µM.  L18 and 54M peptides were added at a 1:1 molar ratio to cpSRP43. Briefly, 
protein was incubated at 4 °C in a D2O buffer for a range of exchange times (0s, 10s, 30s, 60s, 
900s, and 3600s) before quenching the exchange reaction with an acidic quench solution (pH 
2.4) containing 3M urea and 1% TFA. All mixing and pepsin digestions were carried out on a 
LEAP Technologies Twin HTS PAL liquid handling robot housed inside a temperature 
controlled fridge. Protein digestion was performed in-line with chromatography using an 
immobilized pepsin column. Mass spectra were acquired on a Q Exactive hybrid quadrupole-
Orbitrap mass spectrometer (ThermoFisher Scientific).  
Peptides were identified using tandem MS/MS experiments performed with QExactive 
(Thermo Fisher Scientific, San Jose, CA) over a 70 min linear gradient. Product ion spectra were 
acquired in a data-dependent mode and the five most abundant ions were selected for the product 
ion analysis per scan event.  The MS/MS*.raw data files were converted to *.mgf files and then 
submitted to MASCOT (version 2.3 Matrix Science, London, UK) for peptide identification [71].  
The maximum number of missed cleavages was set at 4 with the mass tolerance for precursor 
ions +/- 0.6 Da and for fragment ions +/- 8ppm.  Oxidation to methionine was selected for 
variable modification.  Pepsin was used for digestion and no specific enzyme was selected in the 
MASCOT during the search.  Peptides included in the peptide set used for HDX detection had a 
MASCOT score of 20 or greater. The MS/MS MASCOT search was also performed against a 
decoy (reverse) sequence and false positives were ruled out if they did not pass a 1% false 
discovery rate. The MS/MS spectra of all the peptide ions from the MASCOT search were 
further manually inspected, and only the unique charged ions with the highest MASCOT score 
were included in HDX peptide set.  
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HDX analyses were performed in triplicate, with single preparations of each purified 
protein/complex. The intensity weighted mean m/z centroid value of each peptide envelope was 
calculated and subsequently converted into a percentage of deuterium incorporation. This is 
accomplished determining the observed averages of the undeuterated and fully deuterated spectra 
and using the conventional formula described elsewhere [72]. Statistical significance for the 
differential HDX data is determined by an unpaired t-test for each time point, and is integrated 
into the HDX Workbench software [70], [73]. 
BTFA labeling and 19F NMR. Labeling reactions were performed in 50 mM HEPES (pH 7.5), 
200 mM NaCl. 200 µM concentrations of reduced and degassed single cysteine mutants of 
cpSRP43 were labeled with a 2 mM (tenfold molar excess) of BTFA (Sigma Aldrich) at room 
temperature for 2 hours. Excess BTFA was removed by two rounds of buffer exchange into 50 
mM sodium phosphate (pH 6.5), 150 mM NaCl then supplemented with 10% D2O (NMR 
buffer). The final concentrations of BTFA-labeled samples were 25-100 µM cpSRP43. For urea 
titrations, samples were buffer exchanged into NMR buffer supplemented with either 0.5, 1, or 
6M urea. 1D 19F spectra were acquired at 17 ºC on a Bruker Avance 600 spectrometer equipped 
with a 5mm QCI 1H/19F/13C/15N quadruple resonance cryoprobe with a single axis Z-gradient. 
19F-DOSY measurements were performed and used to estimate the diffusion constant as 
described previously [52]. NMR data were processed with NMRPipe [74]. Peaks were analyzed 
in MestReNova with peak deconvolutions fit to a generalized Lorentzian using simulated 
annealing [75].  
1H-15N NMR spectroscopy. Multidimensional NMR spectra were recorded on a Bruker Avance 
800 spectrometer using a 5mm cryogenic TCI probe with a single Z-axis gradient, and on an 
Avance 900 spectrometer using a 5mm room temperature TXI probe with a triple axis 
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gradient. NMR spectra were acquired at 17 °C using 2H, 15N-labeled protein (∼0.2 mM) in NMR 
buffer containing 10% (vol/vol) D2O at pH 6.5 or with low doses (0 – 0.4 M) of urea. NMR data 
were processed with NMRPipe [74] and analyzed with NMRView Java [76].  
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Figure 1. Substrate, activating ligand, and activating mutations lead to increased global 
protection of the cpSRP43 SBD from solvent exchange as determined by HDX mass 
spectrometry. The differences in HDX incorporation (Figures S1-S4) are mapped onto the 
structure of cpSRP43 for the following comparisons: L18-bound cpSRP43 relative to apo-
cpSRP43 (A); 54M-bound cpSRP43 relative to apo-cpSRP43 (B); superactive cpSRP43(intein) 
relative to wildtype cpSRP43 (C); and cpSRP43-SBD relative to full-length cpSRP43 (D). 
Protection (reduced solvent exchange) or deprotection (increased solvent exchange) are denoted 
by pseudo-colors as indicated, and gray denotes no change.  
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Figure 2. The cpSRP54 M-domain and substrate induce immobilization of spin probes across the 
ankyrin repeat domain and the BH of cpSRP43. (A) Structure of the cpSRP43 SBD highlighting 
residues used for SDSL-EPR analyses. (B) The chaperone activities of single cysteine cpSRP43 
mutants were analyzed using the turbidity assay. Reactions used 1 µM LHCP and 2.5 µM WT or 
mutant cpSRP43. All comparisons were relative to cysteineless cpSRP43(C175A, C297S), 
which is denoted as WT. (C) EPR spectra for spin labels at indicated positions in apo-cpSRP43 
(black), cpSRP43 bound to 54M (red), and cpSRP43 bound with both 54M and LHCP (green). 
The insets show a zoom-in of the spectra at 3450-3475 G, which contain the peaks reporting on 
the mobile and immobile populations of the spin probe. (D) Summary of the effects of 54M and 
LHCP on the central line width (H0) of the spectra for spin labels at various positions in the 
SBD, quantified from the data in part C. All values are reported as mean ± S.D., with n ≥ 2. 
  
35 
 
 
 
Figure 3 Analysis of the19F NMR spectra of BTFA-labeled cpSRP43. (A) Composite structural 
model of cpSRP43 based on the coordinates for SBD-CD2 (PDB: 3UI2) and CD2-CD3 (PDB: 
5E4W). BTFA terminal carbons are shown as labeled spheres. The individual domains are 
colored to match the diagram in C. Interacting peptides from binding partners (L18, 54M) are 
indicated. (B) Example of a deconvolution of the 19F spectrum for E236C-BTFA, with the 
experimental data in black, individual component peaks in blue, and the sum of the component 
peaks in red. Three parameters can be extracted: the chemical shift of the peak center (ppm), the 
peak width (ppm), and the peak area. (C) Summary of the relative abundance of component 
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cross peaks for the indicated BTFA probe sites in apo cpSRP43, cpSRP43+54M, and 
cpSRP43+54M+L18, calculated from deconvolution of the 19F NMR spectra for BTFA shown in 
Figure 3B. (D) Comparison of the chemical shift and peak width for component cross peaks for 
the closed (blue circles) and open (red circles) conformations in apo cpSRP43 (left), cpSRP43 
bound to 54M peptide (middle), and cpSRP43 bound to both the 54M and L18 peptides. The size 
of the circle indicates the relative abundance of the component peak. (E) Summary of the line 
widths of the 19F resonances in the closed (blue) and open (red) conformations of apo cpSRP43 
for the indicated BTFA-labeled sites. 
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Figure 4. Low doses of urea drive cpSRP43 into the open state.   
(A) Effect of urea on the relative intensity of the component cross peaks for Ser92 in the TROSY 
spectra of 2H, 15N-labeled apo cpSRP43. (B) Quantification of the data in part A. (C) Summary 
of the effects of urea on the relative intensities of the open conformation cross peaks at the 
indicated residues. Relative intensities were determined from cross peak heights. (D) 19F 1D 
NMR spectra on BTFA-labeled apo cpSRP43 at 0 M (green), 0.5 M (blue), 1 M (purple), and 6 
M (yellow) urea. The assigned peaks are labeled by conformation: closed (c), open 1 (o1), open 
2 (o2), and unfolded (u). (E) Relative populations of closed (blue), open 1 (red), and open 2 
(pink), and unfolded (gray) peaks at the indicated urea concentrations. 
The image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the file again. If the red x still appears, you may have to delete the image and then insert it again.
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Figure 5. Disruption of intra- and inter-helical contacts in the bridging helix compromises 
chaperone activity and renders cpSRP43 more dependent on cpSRP54. (A) Structure of the 
SBD-CD2 fragment of cpSRP43 highlighting the residues in the BH subject to mutational 
analyses. Colors indicate different mutational effects on the chaperone activity of cpSRP43. (B) 
Time courses for the aggregation of LHCP, monitored by turbidity at 360 nm, upon dilution into 
buffer (green) or into solutions containing mutant cpSRP43(I259C) in the absence (black) and 
presence of the indicated regulatory factors: 54M (light blue); 54M peptide (dark blue); mutant 
54M lacking the basic C-terminal residues that bind cpSRP43 (54M(RRKRK); orange). (C) 
Time courses for aggregation of LHCP upon dilution into buffer (green), or into solutions 
containing mutant cpSRP43(E256C) in the absence (black) and presence (light blue) of the 
cpSRP54 M-domain. (D, E) Summary of the chaperone activities of indicated BH mutants in the 
absence (D) and presence (E) of the cpSRP54 M-domain, quantified from the degree of 
solubilization of LHCP at the indicated chaperone concentrations based on turbidity 
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measurements. (F) Mutations in the BH disrupt chaperone activity even in the absence of CD2 
and CD3. All mutations were constructed in cysteinless cpSRP43 (C175A, C297S), which is 
denoted as WT in this figure. 
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Figure 6. Model for allosteric regulation of cpSRP43’s chaperone activity. In the open 
conformation, the SBD’s ankyrin repeat domain and BH are flexible and disordered, resulting in 
an inactive chaperone. The interaction of cpSRP43 with the cpSRP54 M-domain or with the L18 
motif on the LHCP substrate stabilizes the closed conformation, in which the Ankyrin repeat 
domain is more stably folded. The enables the formation of contiguous contact surfaces on the 
cpSRP43-SBD for the substrate TMDs and thus high chaperone activity. The interaction of 
cpSRP54 with cpFtsY delivers the transit complex to the Alb3 translocase at the thylakoid 
membrane, where Alb3 triggers cpSRP43 to release LHCP and mediates its insertion into the 
membrane. 
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• Substrate and activating ligands drives cpSRP43 from a chaperone-inactive, open conformation 
to a chaperone-active, closed conformation. 
• The open conformation of cpSRP43 is characterized by a disordered Ankyrin repeat domain.  
• Binding of cpSRP54 at chromodomain 2 drives a cooperative disorder-to-order transition in the 
Ankyrin repeat domain that propagates to chromodomain 1. 
• The bridging helix of cpSRP43 mediates long-range allosteric communication between the 
ligand binding site and the substrate binding domain.  
 
 
